detection of genotype

GENETIC6 trials

Sponsors

Cui Yimin

Conditions

Accurate MedicationApixabanCapecitabineDabigatranDocetaxelDrug-Related Side Effects and Adverse ReactionsEnalapril Adverse ReactionNOACs

Unknown Phase

Impact of Biomarkers on Pharmacokinetics and Pharmacodynamics of Ticagrelor

Cui YiminAccurate Medication, Pharmacodynamics, Pharmacogenomics +2

Start: 2017-05-31End: 2021-12-31Target: 400Updated: 2020-12-22

Impact of Biomarkers on Pharmacokinetics and Pharmacodynamics of Direct Oral Anticoagulants

Cui YiminAccurate Medication, Apixaban, Dabigatran +6

Start: 2017-06-06End: 2021-12-31Target: 1200Updated: 2020-12-22

Association of Genetic Polymorphisms With Capecitabine-based Chemotherapy Toxicities in Chinese Solid Tumor Patients

Cui YiminCapecitabine, Drug-Related Side Effects and Adverse Reactions, Pharmacogenetics +2

Start: 2017-12-28End: 2019-12-31Target: 2200Updated: 2019-08-28

A Pharmacogenomics Study of Safety and Efficacy of Enalapril or Enalapril-Folic Acid Therapy in Hypertensive Patients.

Cui YiminEnalapril Adverse Reaction, Pharmacogenomics, Stroke

Start: 2017-08-16End: 2020-06-30Target: 2200Updated: 2019-08-28

Association of Genetic Polymorphisms With Docetaxel-based Chemotherapy Toxicities in Chinese Solid Tumor Patients

Cui YiminDocetaxel, Drug-Related Side Effects and Adverse Reactions, Pharmacogenetics +2

Start: 2017-09-25End: 2019-12-31Target: 2200Updated: 2019-08-28

A Pharmacogenomics Study of Simvastatin-Induced Adverse Drug Reaction

Cui YiminAccurate Medication, Pharmacogenomics, Simvastatin Adverse Reaction

Start: 2018-08-31End: 2018-12-31Target: 2200Updated: 2018-05-22

Related Papers

Genetic variants influenced the risk of bleeding and pharmacodynamics of rivaroxaban in patients with nonvalvular atrial fibrillation: A multicentre prospective cohort study

Clinical and Translational Medicine2023-05-0112 citations

Identification of genetic biomarkers associated with pharmacokinetics and pharmacodynamics of apixaban in Chinese healthy volunteers

Expert Opinion on Drug Metabolism & Toxicology2023-01-025 citations

Hemoclot Thrombin Inhibitor Assay and Expected Peak-Trough Levels of Dabigatran: A Multicenter Study

Frontiers in Cardiovascular Medicine2022-07-221 citations

SLC4A4, FRAS1, and SULT1A1 Genetic Variations Associated With Dabigatran Metabolism in a Healthy Chinese Population

Frontiers in Genetics2022-05-137 citations

Effect of Genetic Polymorphism Including NUP153 and SVEP1 on the Pharmacokinetics and Pharmacodynamics of Ticagrelor in Healthy Chinese Subjects.

2022-04-302 citations

Identification of Potential Biological Factors Affecting the Treatment of Ticagrelor After Percutaneous Coronary Intervention in the Chinese Population

Pharmacogenomics and Personalized Medicine2022-01-011 citations

<i>Pnpt1</i> and <i>Pcgf3</i> Variants Associated with Angiotensin-Converting Enzyme Inhibitor-Induced Cough: a Nested Case–Control Genome-Wide Study

Pharmacogenomics2020-05-138 citations